期刊文献+

Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene 被引量:3

Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene
下载PDF
导出
摘要 AIM:To study the expression of human insulin gene in gastrointestinal tracts of diabetic rats. METHODS: pCMV.Ins, an expression plasmid of the human insulin gene, wrapped with chitosan nanoparticles, was transfected to the diabetic rats through lavage and coloclysis, respectively. Fasting blood glucose and plasma insulin levels were measured for 7 d. Reverse transcription polymerase chain reaction (RT-PCR) analysis and Western blot analysis were performed to confirm the expression of human insulin gene. RESULTS: Compared with the control group, the fasting blood glucose levels in the lavage and coloclysis groups were decreased significantly in 4 d (5.63 ± 0.48 mmol/L and 5.07 ± 0.37 mmol/L vs 22.12 ± 1.31 mmol/L, respectively, P < 0.01), while the plasma insulin levels were much higher (32.26 ± 1.81 μIU/mL and 32.79 ± 1.84 μIU/mL vs 14.23 ± 1.38 μIU/mL, respectively, P < 0.01). The human insulin gene mRNA and human insulin were only detected in the lavage and coloclysis groups. CONCLUSION: Human insulin gene wrapped with chitosan nanoparticles can be successfully transfected to rats through gastrointestinal tract, indicating that chitosan is a promising non-viral vector. AIM: To study the expression of human insulin gene in gastrointestinal tracts of diabetic rats. METHODS: pCMV.Ins, an expression plasmid of the human insulin gene, wrapped with chitosan nanoparticles, was transfected to the diabetic rats through lavage and coloclysis, respectively. Fasting blood glucose and plasma insulin levels were measured for 7 d. Reverse transcription polymerase chain reaction (RT-PCR) analysis and Western blot analysis were performed to confirm the expression of human insulin gene. RESULTS: Compared with the control group, the fasting blood glucose levels in the lavage and coloclysis groups were decreased significantly in 4 d (5.63±0.48 mmol/L and 5.07±0.37 mmol/L vs 22.12±1.31 mmol/L, respectively, P 〈 0.01), while the plasma insulin levels were much higher (32.26±1.81μIU/mL and 32.79±1.84μIU/mL vs 14.23±1.38μIU/mL, respectively, P 〈 0.01). The human insulin gene mRNA and human insulin were only detected in the lavage and coloclysis groups. CONCLUSION: Human insulin gene wrapped with chitosan nanoparticles can be successfully transfected to rats through gastrointestinal tract, indicating that chitosan is a promising non-viral vector.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第26期4209-4215,共7页 世界胃肠病学杂志(英文版)
关键词 1型糖尿病 基因治疗 基因表达 壳聚糖纳米颗粒 人胰岛素基因 Gastrointestinal tract Human insulin gene Gene expression Diabetes mellitus Chitosan nanoparticle
  • 相关文献

参考文献36

  • 1[1]Dieterle C,Brendel MD,Seissler J,Eckhard M,Bretzel RG,Landgraf R.[Therapy of diabetes mellitus.Pancreas transplantation,islet transplantation,stem cell and gene therapy] Internist (Bed) 2006; 47:489-496,498-501
  • 2[2]Samson SL,Chan L.Gene therapy for diabetes:reinventing the islet.Trends Endocrinol Metab 2006; 17:92-100
  • 3[3]Shapiro AM,Lakey JR,Ryan EA,Korbutt GS,Toth E,Warnock GL,Kneteman NM,Rajotte RV.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med 2000; 343:230-238
  • 4[4]Lau J,Mattsson G,Carlsson C,Nyqvist D,Kohler M,Berggren PO,Jansson L,Carlsson PO.Implantation sitedependent dysfunction of transplanted pancreatic islets.Diabetes 2007; 56:1544-1550
  • 5[5]Li M,Inaba M,Guo KQ,Hisha H,Abraham NG,Ikehara S.Treatment of streptozotocin-induced diabetes mellitus in mice by intra-bone marrow bone marrow transplantation plus portal vein injection of beta cells induced from bone marrow cells.Int J Hematol 2007; 86:438-445
  • 6[6]-9 Brenner S,Ryser MF,Whiting-Theobald NL,Gentsch M,Linton GF,Malech HL.The late dividing population of gamma-retroviral vector transduced human mobilized peripheral blood progenitor cells contributes most to genemarked cell engraftment in nonobese diabetic/severe combined immunodeficient mice.Stem Cells 2007; 25:1807-1813
  • 7[10]Timper K,Seboek D,Eberhardt M,Linscheid P,Christ Crain M,Keller U,Muller B,Zulewski H.Human adipose tissue-derived mesenchymal stem cells differentiate into insulin,somatostatin,and glucagon expressing cells.Biochem Biophys Res Commun 2006; 341:1135-1140
  • 8[11]Fukushima M,Hattori Y,Tsukada H,Koga K,Kajiwara E,Kawano K,Kobayashi T,Kamata K,Maitani Y.Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection.J Gene Med 2007; 9:976-985
  • 9[12]Yoo HS,Mazda O,Lee HY,Kim JC,Kwon SM,Lee JE,Kwon IC,Jeong H,Jeong YS,Jeong SY.In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector.J Control Release 2006; 112:139-144
  • 10[13]Lu YC,Sternini C,Rozengurt E,Zhukova E.Release of transgenic human insulin from gastric g cells:a novel approach for the amelioration of diabetes.Endocrinology 2005; 146:2610-2619

同被引文献8

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部